Basic Search
|
Geographic Searches
|
Advanced Search |
Megadeals
Subsidy Tracker Parent Company Summary
Parent Company Name: Gilead Sciences
Ownership Structure: publicly traded (ticker symbol GILD)
Headquartered in: California
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
| State/Local | $24,378,529 | 36 |
| Federal (grants and allocated tax credits) | $2,262,985 | 4 |
| TOTAL | $26,641,514 | 40 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $0 | 0 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $4,500,000 | 1 |
| TOTAL | $4,500,000 | 1 |
Time Period for State and Local Awards: Earliest year of data: 2007. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2013.
Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page
here.
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
| North Carolina | $12,854,438 | 13 |
| California | $9,192,393 | 5 |
| Washington | $1,869,398 | 16 |
| Maryland | $250,000 | 1 |
| Pennsylvania | $212,300 | 1 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
| Company | Location | Subsidy Source | Year | Subsidy Value  . | Loan/Bailout Value | Type of Subsidy |
| Gilead Sciences, Inc. | North Carolina | state | 2021 | $9,997,500 | | grant |
| Kite Pharma, Inc. | California | state | 2016 | $7,000,000 | | tax credit/rebate |
| Kite Pharma, Inc. | California | state | 2015 | $1,800,000 | | tax credit/rebate |
| IMMUNOMEDICS, INC. | United States | federal | 2013 | $1,615,021 | | federal grant |
| Gilead Sciences, Inc. | North Carolina | state | 2011 | $550,523 | | tax credit/rebate |
| Gilead Sciences, Inc. | North Carolina | state | 2013 | $547,098 | | tax credit/rebate |
| Gilead Sciences, Inc. | North Carolina | state | 2013 | $547,098 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2014 | $403,872 | | tax credit/rebate |
| IMMUNOMEDICS, INC. | United States | federal | 2016 | $394,508 | | federal grant |
| Gilead Sciences, Inc. | North Carolina | state | 2010 | $367,742 | | tax credit/rebate |
| GILEAD SCIENCES, INC. | Washington | state | 2017 | $333,444 | | tax credit/rebate |
| GILEAD SCIENCES, INC. | Washington | state | 2018 | $333,444 | | tax credit/rebate |
| Gilead Sciences, Inc. | North Carolina | state | 2015 | $319,628 | | tax credit/rebate |
| Gilead Sciences, Inc. & Subsidiaries | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
| GILEAD SCIENCES INC | Pennsylvania | state | 2020 | $212,300 | | tax credit/rebate |
| GILEAD SCIENCES INC | California | state | 2015 | $191,250 | | training reimbursement |
| GILEAD SCIENCES, INC. | California | state | 2011 | $190,995 | | training reimbursement |
| Gilead Sciences, Inc. | North Carolina | state | 2017 | $181,044 | | tax credit/rebate |
| Gilead Sciences, Inc. | North Carolina | state | 2018 | $171,783 | | tax credit/rebate |
| Gilead Sciences, Inc. | North Carolina | state | 2016 | $162,288 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2013 | $141,588 | | tax credit/rebate |
| IMMUNOMEDICS, INC | United States | federal | 2005 | $134,285 | | federal grant |
| IMMUNOMEDICS, INC | United States | federal | 2003 | $119,171 | | federal grant |
| GILEAD SCIENCES INC | Washington | state | 2012 | $108,730 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2011 | $83,248 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2010 | $72,840 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2008 | $71,546 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2009 | $66,838 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2007 | $63,676 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2013 | $41,681 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2014 | $41,681 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2015 | $41,681 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2016 | $41,681 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2011 | $11,724 | | tax credit/rebate |
| GILEAD SCIENCES INC | Washington | state | 2012 | $11,724 | | tax credit/rebate |
| KITE PHARMA INC | California | state | 2018 | $10,148 | | training reimbursement |
| Gilead Palo Alto, Inc. | North Carolina | state | 2011 | $3,743 | | tax credit/rebate |
| Gilead Palo Alto, Inc. | North Carolina | state | 2013 | $2,237 | | tax credit/rebate |
| Gilead Palo Alto, Inc. | North Carolina | state | 2013 | $2,237 | | tax credit/rebate |
| Gilead Palo Alto, Inc. | North Carolina | state | 2010 | $1,517 | | tax credit/rebate |
| Gilead Sciences, Inc. | United States | federal | 2011 | | $4,500,000 | federal loan or loan guarantee |
| KITE PHARMA INC | California | local | 2012 | undisclosed | | tax credit/rebate |
